Rare blood cancer drug Brukinsa to be listed for the first time on Pharmaceutical Benefits Scheme

1 July 2022 - Graeme Anderson had just finished seven days of night shift when he first noticed something didn’t feel ...

Read more →

NHS saves £1.2 billion on medicines over three years

1 July 2022 - The NHS has saved taxpayers £1.2 billion in just three years, while securing cutting-edge treatments for ...

Read more →

Public Summary Documents – March 2022 PBAC meeting

1 July 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2022 PBAC ...

Read more →

New PBS listings from 1 July 2022

1 July 2022 - Vitrakvi (larotrectinib) will list for the first time for the treatment of adult and paediatric patients with ...

Read more →

Australian Medical Association prescribes new regulator to save private health system

30 June 2022 - The Australian Medical Association is calling for a new regulator to oversee the private health system, ...

Read more →

PBS listing for ‘Australian success story’ blood cancer drug

1 July 2022 - A pill that removes the need for chemotherapy for some cancer sufferers has been put on ...

Read more →

New strategic agreements with the medicines industry – PBS website updates

1 July 2022 - Amendments made by the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 give effect to ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2022

1 July 2022 - The July 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Update to continued dispensing arrangements

30 June 2022 - From 1 July 2022, on-going continued dispensing arrangements have been expanded to include additional medicines groups to ...

Read more →

Zanubrutinib for the treatment of adults with Waldenström’s macroglobulinaemia

29 June 2022 - NICE has published a second appraisal consultation document on the use of zanubrutinib for the treatment ...

Read more →

Accuretic supply issue, almost 36,000 New Zealanders taking the blood pressure medicine will need to change treatments

30 June 2022 - PHARMAC has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier ...

Read more →

NICE publishes its 800th technology assessment

29 June 2022 - TAs 799 and 800 are for the same technology. ...

Read more →

The Innovative Medicines Fund - good news for patients but has an opportunity been missed to be more ambitious?

27 June 2022 - NHS England and Improvement has announced the launch of the Innovative Medicines Fund. The ABPI’s Director ...

Read more →

Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy

23 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma

23 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →